ABL

🌟 Exciting News from ABL! 🌟 We’re thrilled to announce the recent award of six new NIH Task Orders under the RAPPS contract to support HIV prevention products in the pediatric population. This award underscores our commitment to advancing HIV prevention and underscores the trust NIH places in ABL's dedicated team and innovative solutions. Our work will focus on expanding and refining strategies to combat HIV among pediatric patients, an area where progress is crucial. Together with NIH, we aim to make a lasting impact in the field of HIV prevention and create brighter futures for vulnerable populations. Read More: https://lnkd.in/eRXFJsXj Stay tuned as we continue our mission to make a difference in public health! #HIVPrevention #PediatricHealth #NIH #DiscoverABL

A warm welcome to our new neighbors BioHub Maryland! ABL is thrilled to have this new workforce training resource right next door and looks forward to seeing their impact on the life sciences talent in our region. #welcome #goodneighbors #workforcedevelopment #DiscoverABL

🌟 Exciting Opportunity to Join Our Team at ABL! 🌟 ABL is looking for passionate individuals to join us on our journey. We believe in fostering a culture of collaboration, creativity, and excellence, where every team member's contributions are valued. Are you someone who thrives in a dynamic environment, is driven by curiosity and continuous improvement, and is looking to make a meaningful difference? If so, we'd love to hear from you! To learn more about our open positions, please visit our careers page at: https://lnkd.in/dBtkrjx Let's create something extraordinary together! 🚀 #NowHiring #JoinOurTeam #DiscoverABL #Opportunities #CareerGrowth

The ABL team was up early and ready to talk CDMO services! Let's connect! #cgmesa24 #DiscoverABL

⏰ ABL is counting down the days to the Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa in Phoenix, AZ, from October 7-9! Our CEO, CSO, and Business Development team are excited to engage with industry leaders, partners, and innovators in the cell and gene therapy space. It's a fantastic opportunity to explore collaborations and discuss the latest advancements in regenerative medicine. If you'll be attending, connect with us via the partnering app, LinkedIn, or at info@ablinc.com. Safe travels ✈️, and see you in Phoenix! 🌵 #CGMesa24 #GeneTherapy #CellTherapy #DiscoverABL #Collaboration

🌟 Exciting News from Contract Pharma in NJ! ABL is here at the Contracting & Outsourcing Conference, ready to discuss our client-forward approach to biotech and biopharma partnerships. If you're looking to explore new opportunities with a highly experienced CDMO, be sure to connect with our business development team: George M. Baskinger Jr. and Erika DS Wachs, who are available today and tomorrow! Say hello 👋 at the event or via Linked In, and let's see how ABL can support your next big project. 🚀 #ContractPharma #Biotech #BusinessDevelopment #Partnerships #DiscoverABL #Networking

What a day! 🌞🥇 On Wednesday, the ABL team gathered for our company picnic and 2nd Annual ABL Olympics—an afternoon full of food, fun, teamwork, and a bit of friendly competition! It was a great opportunity to enjoy the fresh air, connect with colleagues, and celebrate the strong sense of community that makes ABL special. From office chair races and corn eating challenges to recreating a childhood board game (hungry, hungry, humans!) and a Simon says/musical chairs mash-up - everyone brought their A-game! 💪🏽 The energy and enthusiasm were contagious. Congratulations to all the winners, and a huge thanks to the event organizers for making this day a success! 🎉 These moments remind us that it’s not just about the work we do—it’s about the people who make it all happen and coming together as a team. #FunatWork #DiscoverABL #WorkOlympics

🚀 ABL is thrilled to be attending the Contract Pharma Contract and Outsourcing Conference  at the Hyatt Regency in New Brunswick, NJ, on September 26-27!   At ABL, we specialize in viral vector manufacturing and are dedicated to advancing your candidate vaccines and therapeutics through preclinical and clinical development. With our strong foundation in product development, GMP manufacturing, and analytical testing, ABL is at the forefront of producing and testing today’s leading oncolytic viruses, gene therapies, cell therapies, immunotherapies, viral vaccines, and recombinant protein vaccines.   Attending from our business development team will be Erika DS Wachs and George M. Baskinger Jr.. If you’re at the conference, we’d love to connect! Let’s collaborate to bring your therapies to life.   🌐 Learn more at ablinc.com 📧 Contact us at info@ablinc.com   #ViralVector #GeneTherapy #CellTherapy #OncolyticViruses #CDMO #PharmaInnovation #DiscoverABL

As we celebrate Labor Day, we would like to take a moment to honor the dedication, resilience, and hard work of our incredible team at ABL. Every innovation and success we achieve is a direct result of the unwavering commitment and passion of our employees. This day of reflection is a reminder that behind every breakthrough, there are people who strive for excellence and push the boundaries of what's possible. We are proud to stand beside such talented and driven individuals, and we thank them for their continued contributions in our attempts to conquer some of the world's most challenging diseases. Wishing a safe and restful Labor Day to our team, our collaborators and our clients! #LaborDay #DiscoverABL #InnovationThroughPeople #ThankYou

🎉 TWO NEW IDIQ CONTRACTS have been awarded to ABL for translational development of therapeutic biologics! As one of the contract awardees, ABL will provide expert analytical and process development plus GMP manufacturing DS and DP services to the National Center for Advancing Translational Sciences (NCATS) in support of their CMC programs. To learn more: https://lnkd.in/dgCms68j #drugsubstance #drugproduct #biologics #DiscoverABL